Current Ratio of Syndax Pharmaceuticals Inc from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Syndax Pharmaceuticals Inc quarterly Current Ratio in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Syndax Pharmaceuticals Inc Current Ratio for the quarter ending 30 Sep 2025 was 520%, a 42% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Syndax Pharmaceuticals Inc Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 520% -379% -42% 30 Sep 2025
Q2 2025 566% -411% -42% 30 Jun 2025
Q1 2025 671% -353% -34% 31 Mar 2025
Q4 2024 749% -450% -38% 31 Dec 2024
Q3 2024 899% -510% -36% 30 Sep 2024
Q2 2024 977% -659% -40% 30 Jun 2024
Q1 2024 1024% -585% -36% 31 Mar 2024
Q4 2023 1199% -292% -20% 31 Dec 2023
Q3 2023 1409% -162% -10% 30 Sep 2023
Q2 2023 1637% +285% +21% 30 Jun 2023
Q1 2023 1609% +295% +22% 31 Mar 2023
Q4 2022 1491% +241% +19% 31 Dec 2022
Q3 2022 1572% +453% +41% 30 Sep 2022
Q2 2022 1352% +124% +10% 30 Jun 2022
Q1 2022 1314% -19% -1.4% 31 Mar 2022
Q4 2021 1250% +67% +5.7% 31 Dec 2021
Q3 2021 1118% +291% +35% 30 Sep 2021
Q2 2021 1228% +590% +93% 30 Jun 2021
Q1 2021 1333% +884% +197% 31 Mar 2021
Q4 2020 1183% +724% +158% 31 Dec 2020
Q3 2020 827% +321% +64% 30 Sep 2020
Q2 2020 638% +91% +17% 30 Jun 2020
Q1 2020 449% -112% -20% 31 Mar 2020
Q4 2019 459% -122% -21% 31 Dec 2019
Q3 2019 506% -151% -23% 30 Sep 2019
Q2 2019 547% -180% -25% 30 Jun 2019
Q1 2019 560% -314% -36% 31 Mar 2019
Q4 2018 582% -349% -38% 31 Dec 2018
Q3 2018 657% -328% -33% 30 Sep 2018
Q2 2018 727% -361% -33% 30 Jun 2018
Q1 2018 875% -340% -28% 31 Mar 2018
Q4 2017 931% -546% -37% 31 Dec 2017
Q3 2017 985% -713% -42% 30 Sep 2017
Q2 2017 1088% 30 Jun 2017
Q1 2017 1215% 31 Mar 2017
Q4 2016 1477% 31 Dec 2016
Q3 2016 1698% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.